Stratification of Anatomical Imaging Features Between High-Risk and Non-High-Risk Groups in Neuroblastoma

被引:0
|
作者
Wang, Haoru [1 ]
Chen, Xin [1 ]
He, Ling [1 ]
Cai, Jinhua [1 ]
机构
[1] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Radiol,Childrens Hosp,Chongqing Key Lab Child, Minist Educ Key Lab Child Dev & Disorders, 136 Zhongshan Rd 2, Chongqing 400014, Peoples R China
关键词
children; computed tomography; image-defined risk factors; magnetic resonance imaging; neuroblastoma; CLASSIFICATION-SYSTEM; SINGLE;
D O I
10.1177/10732748251315883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study compared anatomical imaging features between high-risk and non-high-risk groups in neuroblastoma with at least one image-defined risk factor (IDRF). It also assessed the diagnostic performance of these features in identifying the high-risk group. Methods: A retrospective analysis of neuroblastoma patients with at least one IDRF was conducted. Imaging features, including estimated tumor volume and IDRFs, were compared between the two groups. The diagnostic performance of these features was assessed using receiver operating characteristic (ROC) curves, and the areas under the ROC curves (AUCs) along with their 95% confidence intervals (CIs) were calculated. Additionally, to internally validate their diagnostic performance, the bootstrap resampling method with 1000 bootstrap resamples was employed. Results: The study included 255 patients (185 high-risk cases, 70 non-high-risk cases). Significant differences were found in estimated tumor volume and IDRF number between the high-risk and non-high-risk groups (P < 0.001). The estimated tumor volume and the IDRF number-based cluster were independent risk factors, and their combination achieved an AUC of 0.801 (95% CI: 0.747-0.848) for high-risk group diagnosis, with the average AUC of the 1000 bootstrap samples of 0.800 (95% CI: 0.798-0.802). In abdominal lesions, specific IDRF categories differed between high-risk and non-high-risk groups (P < 0.05). Conclusion: Our study reveals anatomical imaging differences between high-risk and non-high-risk groups in neuroblastoma with at least one IDRF.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Donor and Recipient Sex Matching and Corneal Graft Failure in High-Risk and Non-High-Risk Patients
    Achiron, Asaf
    Yahalomi, Tal
    Hecht, Idan
    Stanescu, Nir
    Noy, Romi Achiron
    Burgansky-Eliash, Zvia
    Avizemer, Haggai
    Tuuminen, Raimo
    Spierer, Oriel
    JOURNAL OF OPHTHALMOLOGY, 2022, 2022
  • [12] An 18F-FDG PET/CT radiomics nomogram for differentiation of high-risk and non-high-risk patients of the International Neuroblastoma Risk Group Staging System
    Feng, Lijuan
    Lu, Xia
    Yang, Xu
    Kan, Ying
    Sun, Dehui
    Wang, Wei
    Yang, Jigang
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 154
  • [13] Detection of new or additional significant breast disease by MRI compared to standard imaging in "high-risk" and "non-high-risk" patients.
    Banks, Amy Lynn
    Titus, Rachel
    Melnik, Marianne
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [14] CHARACTERIZATION OF HIGH RISK NEUROBLASTOMA. POTENTIAL BIOMARKERS FOR STRATIFICATION OF HIGH RISK NEUROBLASTOMA
    Garrido, Alicia
    Perez, Sara
    Garcia, Marta
    Garcia, Laura
    Lemos, Isadora
    Rodriguez, Eva
    Aznar, Oscar Munoz
    Sunol, Mariona
    Gomez-Gonzalez, Soledad
    Lavarino, Cinzia
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S216 - S217
  • [16] Impact of the relationship between renal pedicles and tumors on surgical outcomes for non-high-risk abdominal neuroblastoma
    Yamamoto, Yuki
    Yoneda, Akihiro
    Miyazaki, Osamu
    Matsumoto, Kimikazu
    Yamagishi, Satoko
    Ichinose, Akinori
    Hirokawa, Tomoya
    Fujiogi, Michimasa
    Ishimaru, Tetsuya
    Shimojima, Naoki
    PEDIATRIC SURGERY INTERNATIONAL, 2024, 41 (01)
  • [17] Treatment of High-Risk Neuroblastoma
    Hizhnikov, A.
    Kazancev, A.
    Kerimov, P.
    Pimenov, R.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S447 - S447
  • [18] Treatment of High-Risk Neuroblastoma
    Sung, Kiwoong
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S3 - S3
  • [19] Treatment of High-Risk Neuroblastoma
    Krystal, Julie
    Foster, Jennifer H.
    CHILDREN-BASEL, 2023, 10 (08):
  • [20] Chemoimmunotherapy for high-risk neuroblastoma
    Kushner, Brian H.
    LANCET ONCOLOGY, 2017, 18 (07): : 845 - 846